Jonathan M. Peacock, President and CEO at Bellerophon Therapeutics, Inc. (BLPH), bought 20,300 shares at $2.72 ($56K) on 2015-12-15, disclosed to the SEC on 2015-12-17.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.72 | 7,500 | $20K | 36.6% |
| 2 | $2.76 | 12,800 | $35K | 63.4% |
| Total | $2.75 avg | 20,300 | $56K | 100% |
| Filing → |
| BLPH | BUY | 2019-01-25 | $1.0M | — | Filing → |
| BLPH | BUY | 2016-05-18 | $7K | — | Filing → |
| BLPH | BUY | 2015-08-20 | $27K | — | Filing → |